Author: Alliance for Trade Enforcement

Did you know that Korea continues to violate its obligations under KORUS to fairly reimburse U.S. biopharmaceutical manufacturers for their new cures and treatments? For example, KORUS requires Korea to set up an independent review process for pricing determinations of new drugs...